VEON LTD (VEON) Fundamental Analysis & Valuation

NASDAQ:VEONUS91822M5022

Current stock price

49.315 USD
-1.09 (-2.17%)
Last:

This VEON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. VEON Profitability Analysis

1.1 Basic Checks

  • VEON had positive earnings in the past year.
  • VEON had a positive operating cash flow in the past year.
  • In multiple years VEON reported negative net income over the last 5 years.
  • VEON had a positive operating cash flow in 4 of the past 5 years.
VEON Yearly Net Income VS EBIT VS OCF VS FCFVEON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

  • VEON has a Return On Assets of 7.31%. This is in the better half of the industry: VEON outperforms 77.27% of its industry peers.
  • VEON's Return On Equity of 46.60% is amongst the best of the industry. VEON outperforms 100.00% of its industry peers.
  • VEON has a Return On Invested Capital of 11.26%. This is amongst the best in the industry. VEON outperforms 81.82% of its industry peers.
  • VEON had an Average Return On Invested Capital over the past 3 years of 11.44%. This is above the industry average of 7.04%.
Industry RankSector Rank
ROA 7.31%
ROE 46.6%
ROIC 11.26%
ROA(3y)-8.89%
ROA(5y)-4.97%
ROE(3y)-96.72%
ROE(5y)-77.85%
ROIC(3y)11.44%
ROIC(5y)10.01%
VEON Yearly ROA, ROE, ROICVEON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

  • With an excellent Profit Margin value of 15.24%, VEON belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
  • VEON's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 22.43%, VEON is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
  • VEON's Operating Margin has been stable in the last couple of years.
  • VEON's Gross Margin of 88.24% is amongst the best of the industry. VEON outperforms 90.91% of its industry peers.
  • VEON's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.43%
PM (TTM) 15.24%
GM 88.24%
OM growth 3Y-3.83%
OM growth 5Y-0.35%
PM growth 3Y-16.1%
PM growth 5Y8.09%
GM growth 3Y-0.11%
GM growth 5Y2.49%
VEON Yearly Profit, Operating, Gross MarginsVEON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. VEON Health Analysis

2.1 Basic Checks

  • VEON has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • VEON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VEON Yearly Shares OutstandingVEON Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VEON Yearly Total Debt VS Total AssetsVEON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 0.29, we must say that VEON is in the distress zone and has some risk of bankruptcy.
  • VEON's Altman-Z score of 0.29 is on the low side compared to the rest of the industry. VEON is outperformed by 68.18% of its industry peers.
  • VEON has a debt to FCF ratio of 4.13. This is a neutral value as VEON would need 4.13 years to pay back of all of its debts.
  • VEON's Debt to FCF ratio of 4.13 is fine compared to the rest of the industry. VEON outperforms 72.73% of its industry peers.
  • VEON has a Debt/Equity ratio of 2.92. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of VEON (2.92) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.92
Debt/FCF 4.13
Altman-Z 0.29
ROIC/WACC1.39
WACC8.12%
VEON Yearly LT Debt VS Equity VS FCFVEON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.95 indicates that VEON may have some problems paying its short term obligations.
  • VEON has a Current ratio (0.95) which is comparable to the rest of the industry.
  • VEON has a Quick Ratio of 0.95. This is a bad value and indicates that VEON is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of VEON (0.94) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.94
VEON Yearly Current Assets VS Current LiabilitesVEON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. VEON Growth Analysis

3.1 Past

  • The earnings per share for VEON have been decreasing by -27.02% on average. This is quite bad
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y-27.02%
EPS Q2Q%-145.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.33%

3.2 Future

  • VEON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 59.10% yearly.
  • The Revenue is expected to grow by 6.08% on average over the next years.
EPS Next Y537.07%
EPS Next 2Y173.08%
EPS Next 3Y101.58%
EPS Next 5Y59.1%
Revenue Next Year6.96%
Revenue Next 2Y5.76%
Revenue Next 3Y5.83%
Revenue Next 5Y6.08%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
VEON Yearly Revenue VS EstimatesVEON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
VEON Yearly EPS VS EstimatesVEON Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15

7

4. VEON Valuation Analysis

4.1 Price/Earnings Ratio

  • VEON is valuated quite expensively with a Price/Earnings ratio of 41.44.
  • VEON's Price/Earnings ratio is in line with the industry average.
  • VEON's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.23.
  • A Price/Forward Earnings ratio of 6.50 indicates a rather cheap valuation of VEON.
  • Based on the Price/Forward Earnings ratio, VEON is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.28. VEON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 41.44
Fwd PE 6.5
VEON Price Earnings VS Forward Price EarningsVEON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VEON indicates a rather cheap valuation: VEON is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.8
EV/EBITDA N/A
VEON Per share dataVEON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • VEON has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as VEON's earnings are expected to grow with 101.58% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y173.08%
EPS Next 3Y101.58%

0

5. VEON Dividend Analysis

5.1 Amount

  • VEON does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

VEON Fundamentals: All Metrics, Ratios and Statistics

VEON LTD

NASDAQ:VEON (3/20/2026, 8:27:04 PM)

49.315

-1.09 (-2.17%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)03-13
Earnings (Next)05-13
Inst Owners26.57%
Inst Owner Change2.27%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap3.48B
Revenue(TTM)N/A
Net Income(TTM)644.00M
Analysts82.5
Price Target72.27 (46.55%)
Short Float %5.83%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.57%
Min EPS beat(2)-21.57%
Max EPS beat(2)78.71%
EPS beat(4)3
Avg EPS beat(4)35.64%
Min EPS beat(4)-21.57%
Max EPS beat(4)78.71%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.06%
Min Revenue beat(2)0%
Max Revenue beat(2)4.12%
Revenue beat(4)2
Avg Revenue beat(4)0.81%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)4.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.61%
EPS NQ rev (1m)-11.29%
EPS NQ rev (3m)-11.29%
EPS NY rev (1m)1.33%
EPS NY rev (3m)7.71%
Revenue NQ rev (1m)-0.79%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 41.44
Fwd PE 6.5
P/S 0.82
P/FCF 2.8
P/OCF 2.81
P/B 2.52
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.19
EY2.41%
EPS(NY)7.58
Fwd EY15.37%
FCF(TTM)17.64
FCFY35.76%
OCF(TTM)17.55
OCFY35.59%
SpS59.81
BVpS19.56
TBVpS-2.17
PEG (NY)0.08
PEG (5Y)N/A
Graham Number22.89
Profitability
Industry RankSector Rank
ROA 7.31%
ROE 46.6%
ROCE 16.42%
ROIC 11.26%
ROICexc 17.35%
ROICexgc 29.39%
OM 22.43%
PM (TTM) 15.24%
GM 88.24%
FCFM 29.48%
ROA(3y)-8.89%
ROA(5y)-4.97%
ROE(3y)-96.72%
ROE(5y)-77.85%
ROIC(3y)11.44%
ROIC(5y)10.01%
ROICexc(3y)19.88%
ROICexc(5y)15.79%
ROICexgc(3y)51.88%
ROICexgc(5y)38.09%
ROCE(3y)16.68%
ROCE(5y)14.59%
ROICexgc growth 3Y65.7%
ROICexgc growth 5Y3.7%
ROICexc growth 3Y46.24%
ROICexc growth 5Y7.89%
OM growth 3Y-3.83%
OM growth 5Y-0.35%
PM growth 3Y-16.1%
PM growth 5Y8.09%
GM growth 3Y-0.11%
GM growth 5Y2.49%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 2.92
Debt/FCF 4.13
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 193.48%
Current Ratio 0.95
Quick Ratio 0.94
Altman-Z 0.29
F-Score6
WACC8.12%
ROIC/WACC1.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y-27.02%
EPS Q2Q%-145.92%
EPS Next Y537.07%
EPS Next 2Y173.08%
EPS Next 3Y101.58%
EPS Next 5Y59.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.33%
Revenue Next Year6.96%
Revenue Next 2Y5.76%
Revenue Next 3Y5.83%
Revenue Next 5Y6.08%
EBIT growth 1Y2.82%
EBIT growth 3Y-2.56%
EBIT growth 5Y-14.99%
EBIT Next Year76.74%
EBIT Next 3Y28.06%
EBIT Next 5Y19.04%
FCF growth 1Y-25.92%
FCF growth 3Y-13.93%
FCF growth 5Y-2.16%
OCF growth 1Y-26.89%
OCF growth 3Y-24.51%
OCF growth 5Y-17.38%

VEON LTD / VEON Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VEON LTD?

ChartMill assigns a fundamental rating of 4 / 10 to VEON.


What is the valuation status of VEON LTD (VEON) stock?

ChartMill assigns a valuation rating of 7 / 10 to VEON LTD (VEON). This can be considered as Undervalued.


What is the profitability of VEON stock?

VEON LTD (VEON) has a profitability rating of 7 / 10.


What is the valuation of VEON LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for VEON LTD (VEON) is 41.44 and the Price/Book (PB) ratio is 2.52.


What is the expected EPS growth for VEON LTD (VEON) stock?

The Earnings per Share (EPS) of VEON LTD (VEON) is expected to grow by 537.07% in the next year.